Chitoran, E.; Rotaru, V.; Ionescu, S.-O.; Gelal, A.; Capsa, C.-M.; Bohiltea, R.-E.; Mitroiu, M.-N.; Serban, D.; Gullo, G.; Stefan, D.-C.;
et al. Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost. Cancers 2024, 16, 2590.
https://doi.org/10.3390/cancers16142590
AMA Style
Chitoran E, Rotaru V, Ionescu S-O, Gelal A, Capsa C-M, Bohiltea R-E, Mitroiu M-N, Serban D, Gullo G, Stefan D-C,
et al. Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost. Cancers. 2024; 16(14):2590.
https://doi.org/10.3390/cancers16142590
Chicago/Turabian Style
Chitoran, Elena, Vlad Rotaru, Sinziana-Octavia Ionescu, Aisa Gelal, Cristina-Mirela Capsa, Roxana-Elena Bohiltea, Madalina-Nicoleta Mitroiu, Dragos Serban, Giuseppe Gullo, Daniela-Cristina Stefan,
and et al. 2024. "Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost" Cancers 16, no. 14: 2590.
https://doi.org/10.3390/cancers16142590
APA Style
Chitoran, E., Rotaru, V., Ionescu, S. -O., Gelal, A., Capsa, C. -M., Bohiltea, R. -E., Mitroiu, M. -N., Serban, D., Gullo, G., Stefan, D. -C., & Simion, L.
(2024). Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost. Cancers, 16(14), 2590.
https://doi.org/10.3390/cancers16142590
